Hot Sale High Quality Mirabegron Powder Mirabegron intermediates with Best Price

Hot Sale High Quality Mirabegron Powder Mirabegron intermediates with Best Price

Min.Order / FOB Price:Get Latest Price

100 Gram	FOB Price: USD 1530.0000

100 Gram

FOB Price: USD 1530.0000

Min.Order :100 Gram
Purity: 99%
Payment Terms : L/C,T/T,Other

Keywords

Mirabegron 223673-61-8 Mirabegron price

Quick Details

Appearance:powder
Application:pharmacetuical,health supplement
PackAge:1kg/bag, 25kg/drum
ProductionCapacity:100|Kilogram|Week
Storage:Far from fire and heat, keep in cool place
Transportation:by express, dhl,tnt,ems by air, by sea

Superiority:

Free sample, low freight, fast delivery, payment assurance, 24 hours service,high purity, good effect,good feedback, lead time:1-3 days, payment terms: TT, alibaba, , factory supplier, recruit overseas agents, welcome inquiry.

Details:

Hot Sale High Quality Mirabegron 223673-61-8 with Best Price

Product Name: Mirabegron

Appearance: White powder

Application : Pharmaceutical raw materials

Factory: Large Output

Purity: 99%

MOQ:1 kg

Shelf life : 2 Years

Brand:HNB

Mirabegron is a selective beta 3 - epinephrine stimulant for bladder hyperactivity disorder.

Name	Mirabegron
Synonyms	2-Amino-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-4-thiazoleacetamide
Brand	Salus
Molecular Formula	C21H24N4O2S
Molecular Weight	396.51
CAS Registry Number	223673-61-8

What is Mirabegron

Mirabegron is a selective beta 3 - epinephrine stimulant for bladder hyperactivity disorder.

Indications: Mirabegron is used to treat urinary bladder urgency, frequency of urination, and urinary incontinence.
There are two known crystalline types (alpha and beta).

Application:

For special people

(1) Pregnancy is only used if the benefit to the mother exceeds the potential risk to the fetus.

(2) Lactating mother: It is expected that Myrbetriq will be excreted in human milk, and breastfeeding mothers are not recommended.

(3) Children: Children with the safety and efficacy of Myrbetriq have not yet been established.

(4) Elderly: It is recommended that elderly patients do not adjust the dose.